AF and ER treatment also modified the phosphorylation of key ERBBs including EGFR, ERBB2 and ERBB3, which all exhibited significantly decreased phosphorylation in both AF- and ER-treated mice (Fig. 4G-J). The gene discussed is EGFR; the disease is atrial fibrillation.